High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus (original) (raw)

• Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J . Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 2001; 294: 1540–1543.
  Article CAS Google Scholar
• Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T . Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 70: 562–569.
  CAS PubMed PubMed Central Google Scholar
• Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK . Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005; 52: 1491–1503.
  Article CAS Google Scholar
• Ronnblom LE, Alm GV, Oberg KE . Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990; 227: 207–210.
  Article CAS Google Scholar
• Niewold TB, Swedler WI . Systemic lupus erythematosus arising during interferon-α therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005; 24: 178–181.
  Article Google Scholar
• Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711–723.
  Article CAS Google Scholar
• Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG et al. Coordinate overexpression of interferon-_α_-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3958–3967.
  Article CAS Google Scholar
• Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610–2615.
  Article CAS Google Scholar
• Tsao BP, Grossman JM, Riemekasten G, Strong N, Kalsi J, Wallace DJ et al. Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2678–2685.
  Article Google Scholar
• Scofield RH, Bruner GR, Harley JB, Namjou B . Autoimmune thyroid disease is associated with a diagnosis of secondary Sjogren's syndrome in familial systemic lupus. Ann Rheum Dis 2007; 66: 410–413.
  Article Google Scholar
• Ioannou Y, Isenberg DA . Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 2000; 43: 1431–1442.
  Article CAS Google Scholar
• Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528–537.
  Article CAS Google Scholar
• Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–555.
  Article CAS Google Scholar
• Hua J, Kirou K, Lee C, Crow MK . Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006; 54: 1906–1916.
  Article CAS Google Scholar
• Jabs WJ, Hennig C, Zawatzky R, Kirchner H . Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-α and IFN-beta. J Interferon Cytokine Res 1999; 19: 463–469.
  Article CAS Google Scholar
• Risch N . Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990; 46: 222–228.
  CAS PubMed PubMed Central Google Scholar
• Rybicki BA, Elston RC . The relationship between the sibling recurrence-risk ratio and genotype relative risk. Am J Hum Genet 2000; 66: 593–604.
  Article CAS Google Scholar
• Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L . Induction of interferon-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004; 50: 1861–1872.
  Article Google Scholar
• Ramos PS, Kelly JA, Gray-McGuire C, Bruner GR, Leiran AN, Meyer CM et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006; 7: 417–432.
  Article CAS Google Scholar
• Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000; 9: 664–671.
  Article CAS Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533.
  Article CAS Google Scholar
• Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005; 52: 1185–1195.
  Article CAS Google Scholar
• Lovgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Ronnblom L . Induction of interferon-α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum 2006; 54: 1917–1927.
  Article Google Scholar
• Consortium. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 2005; 437: 69–87.
  Article Google Scholar
• Wang ET, Kodama G, Baldi P, Moyzis RK . Global landscape of recent inferred Darwinian selection for Homo sapiens. Proc Natl Acad Sci USA 2006; 103: 135–140.
  Article CAS Google Scholar
• Taniguchi T, Takaoka A . A weak signal for strong responses: interferon-α/beta revisited. Nat Rev Mol Cell Biol 2001; 2: 378–386.
  Article CAS Google Scholar
• Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003; 100: 1896–1901.
  Article CAS Google Scholar
• Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007; 104: 6758–6763.
  Article CAS Google Scholar
• Kozyrev SV, Lewen S, Reddy PM, Pons-Estel B, Witte T, Junker P et al. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1234–1241.
  Article CAS Google Scholar
• von Wussow P, Jakschies D, Hartung K, Deicher H . Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 1988; 8: 225–230.
  Article CAS Google Scholar
• Griffiths AJF, Gelbart WM, Miller JH, Lewontin RC . Modern Genetic Analysis, 7th edn. WH Freeman Publishers: New York, NY, 1999.
  Google Scholar
• Olson JM, Witte JS, Elston RC . Association within twin pairs for a dichotomous trait. Genet Epidemiol 1996; 13: 489–499.
  Article CAS Google Scholar